|
|
||||
|
From SARS to Avian Flu: Vaccines on the Scene
An uncertain market slowed SARS vaccine research; are the same forces at work with H5N1?
Email: Jane Parry - jparry@the-scientist.com The Scientist 2005, 19(5):34
|
||||
|
|
||||
|
When SARS struck more than 8,000 people and killed nearly 800 in the spring of 2003, the world clamored to know when a vaccine against the deadly virus would come to the rescue. Vaccine manufacturers and health institutes in Asia, the United States, and Europe rose to the challenge and began to work on vaccine candidates.
|
|
|||||||||
|
|||||||||
|